DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/58dptr/global_industry) has announced the addition of the "Global Industry Insight: Human Insulin Market Development and Demand Forecast to 2020" report to their offering.
Increasing usage of insulin pens for the administration of insulin helps to inject insulin accurately. In addition, growing demand of biosimilar drugs due to its cost effectiveness is an opportunity for the growth of the market.
Human insulin market is growing moderately due to increase in prevalence of diabetic population, rise in geriatric population, rising awareness of diabetes and rising prevalence of obesity. However, strict regulatory requirements for approval of insulin and high cost of analog are inhibiting the growth of the global human insulin market.
Globally, modern human insulin has the largest market share and is also the fastest growing human insulin type. In addition, long acting human insulin has the largest market share in the modern human insulin market, and premixed human insulin is the fastest growing modern human insulin in the market. Long acting human insulin is prescribed by physicians for the treatment of type 2 diabetes.
- Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
- Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
- Uncovers potential demands in the market
Key Topics Covered:
1 Research Scope and Methodology
2 Executive Summary
3 Market Outlook
4 Global Market Size and Forecasts (2011 - 2020)
5 Global Market Breakdown by Type
6 Global Traditional Human Insulin Market Breakdown by Type
7 Global Modern Human Insulin Market Breakdown by Type
8 Global Market Breakdown by Brand
9 Global Market Breakdown by Region
10 Competitive Analysis and Market Share
11 Company Profiles
- Biocon Ltd.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- GlaxoSmithKline Plc
- Merck & Co.
- Novo Nordisk A/S
- Oramed Pharmaceuticals, Inc.
- Pfizer, Inc.
TonghuaDongbao Pharmaceuticals Co., Ltd
For more information visit http://www.researchandmarkets.com/research/58dptr/global_industry